{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:06:58Z","timestamp":1763755618529,"version":"3.45.0"},"reference-count":19,"publisher":"Oncology Nursing Society (ONS)","issue":"s6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.1188\/13.cjon.s2.7-11","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T21:12:36Z","timestamp":1385500356000},"page":"7-11","source":"Crossref","is-referenced-by-count":7,"title":["The Changing Landscape of Multiple Myeloma"],"prefix":"10.1188","volume":"17","author":[{"given":"Sandra","family":"Kurtin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Faiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1158\/1078-0432.CCR-12-2922","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: A review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease","volume":"19","author":"A. Agarwal","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"2","unstructured":"American Cancer Society. (2013). Cancer facts and figures 2013. Retrieved from <a target=\"_blank\" href='http:\/\/www.cancer.org\/research\/cancerfactsfigures\/cancerfactsfigures\/cancer-facts-figures-2013'>http:\/\/www.cancer.org\/research\/cancerfactsfigures\/cancerfactsfigures\/cancer-facts-figures-2013<\/a>"},{"key":"3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.thj.6200312","article-title":"Myeloma management guidelines: A consensus report from Scientific Advisors of the International Myeloma Foundation","volume":"4","author":"B. Durie","year":"2003","journal-title":"Hematology Journal"},{"issue":"2","key":"4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1188\/13.CJON.S2.33-41","article-title":"Clinical update in bone marrow transplantation in multiple myeloma","volume":"17","author":"B. Faiman","year":"2013","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: Evolving genetic events and host interactions","volume":"2","author":"W. Kuehl","year":"2002","journal-title":"Nature Reviews: Cancer"},{"key":"6","unstructured":"Kumar, S., Dispenzieri, A., Gertz, M., Lacy, M., Lust, J., Hayman, S., \u2026 Rajkumar, S. V. (2012). <i>Continued improvement in survival in multiple myeloma and the impact of novel agents<\/i> [Abstract 3972]. Retrieved from <a target=\"_blank\" href='http:\/\/myeloma.org\/pdfs\/ASH2012_Kumar_3865.pdf'>http:\/\/myeloma.org\/pdfs\/ASH2012_Kumar_3865.pdf<\/a>"},{"issue":"2","key":"7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1188\/13.CJON.S2.25-32","article-title":"Caregivers of multiple myeloma survivors","volume":"17","author":"S. Kurtin","year":"2013","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"2","key":"8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1188\/13.CJON.S2.43-47","article-title":"Autologous hematopoietic stem cell transplantation for multiple myeloma: Frequently asked questions","volume":"17","author":"P. Mangan","year":"2013","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"2","key":"9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1188\/13.CJON.S2.13-24","article-title":"Autologous hematopoietic stem cell transplantation for patients with multiple myeloma. An overview for nurses in community practice","volume":"17","author":"T. Miceli","year":"2013","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"10","unstructured":"National Cancer Institute. (2010). SEER stat fact sheets: Myeloma. Retrieved from <a target=\"_blank\" href='http:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html'>http:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html<\/a>"},{"key":"11","unstructured":"National Comprehensive Cancer Network. (2013). NCCN Clinical Practice Guidelines in Oncology: Multiple myeloma [v.1.2013]. Retrieved from <a target=\"_blank\" href='http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#myeloma'>http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#myeloma<\/a>"},{"key":"12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"A. Palumbo","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"13","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1182\/blood-2012-05-423202","article-title":"Have drug combinations supplanted stem cell transplantation in myeloma?","volume":"120","author":"A. Palumbo","year":"2012","journal-title":"Blood"},{"key":"14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.canep.2013.01.008","article-title":"Multiple myeloma and occupation: A polled analysis by the International Multiple Myeloma Consortium","volume":"37","author":"C. Perotta","year":"2013","journal-title":"Cancer Epidemiology"},{"key":"15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ajh.21913","article-title":"Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management","volume":"86","author":"S. Rajkumar","year":"2010","journal-title":"American Journal of Hematology"},{"key":"16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"S. Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"3","key":"17","first-page":"22","article-title":"New directions in therapy for multiple myeloma","volume":"6","author":"D. Siegel","year":"2009","journal-title":"Community Oncology"},{"key":"18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood-2005-03-1038","article-title":"Bone marrow angiogenesis in multiple myeloma","volume":"20","author":"A. Vacca","year":"2006","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","article-title":"Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies","volume":"47","author":"A. Wallin","year":"2011","journal-title":"European Journal of Cancer"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/F5101028G5312156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:54:18Z","timestamp":1763754858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/17\/6\/supplement-december-2013-multiple-myeloma\/changing-landscape"}},"subtitle":["Implications for Oncology Nurses"],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":19,"journal-issue":{"issue":"s6","published-print":{"date-parts":[[2013,12,1]]}},"alternative-id":["F5101028G5312156"],"URL":"https:\/\/doi.org\/10.1188\/13.cjon.s2.7-11","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}